Phillip Dolamore
No más puestos en curso
Historial de carrera de Phillip Dolamore
Antiguos cargos conocidos de Phillip Dolamore.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Corporate Officer/Principal | 01/01/2008 | - |
Estadísticas
Internacional
| Reino Unido | 3 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 3 |
Sectorial
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
| Glaxo, Inc. | |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
- Bolsa de valores
- Insiders
- Phillip Dolamore
- Experiencia
